A type of diabetes drug might help protect joint cartilage in arthritis by stopping cells from leaking important building blocks.
Evidence from Studies
Supporting (2)
Community contributions welcome
Liraglutide, a glucagon-like peptide 1 receptor agonist, exerts analgesic, anti-inflammatory and anti-degradative actions in osteoarthritis
The study tested a diabetes drug called liraglutide, which activates GLP-1 receptors, and found it helps protect cartilage in arthritic joints by reducing the activity of destructive enzymes.
The study looks at the same type of drugs mentioned in the claim and finds they help protect cartilage in joints, which supports the idea that they slow down joint damage in arthritis.
Contradicting (0)
Community contributions welcome
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.